HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orit Itzhaki Selected Research

Injections

1/2020Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Orit Itzhaki Research Topics

Disease

29Neoplasms (Cancer)
01/2024 - 03/2004
26Melanoma (Melanoma, Malignant)
01/2023 - 03/2006
5Experimental Melanoma
01/2009 - 03/2004
4Lymphoma (Lymphomas)
01/2009 - 03/2004
3Leukemia
05/2024 - 01/2020
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2017
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 12/2018
2Clinical Deterioration
09/2019 - 05/2009
1cell-associated neurotoxicity
08/2023
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2022
1Disease Progression
12/2022
1Lymphopenia (Lymphocytopenia)
01/2021
1Neutropenia
01/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2019
1Adenocarcinoma
01/2019
1Lung Neoplasms (Lung Cancer)
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Pathologic Processes
04/2011
1Renal Cell Carcinoma (Grawitz Tumor)
01/2009
1Tetraploidy
03/2008

Drug/Important Bio-Agent (IBA)

13Chimeric Antigen ReceptorsIBA
08/2023 - 01/2013
4MicroRNAs (MicroRNA)IBA
06/2021 - 04/2011
4Interleukin-2 (IL2)IBA
09/2013 - 01/2009
3Biomarkers (Surrogate Marker)IBA
01/2017 - 09/2013
2Glucose (Dextrose)FDA LinkGeneric
05/2024 - 09/2023
2Galactose (Galactopyranose)FDA LinkGeneric
05/2024 - 09/2023
2Messenger RNA (mRNA)IBA
02/2019 - 11/2018
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2017 - 01/2013
2Levamisole (Decaris)FDA Link
01/2009 - 07/2004
2O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
01/2009 - 04/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2009 - 03/2004
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2009 - 03/2004
2Immunologic Factors (Immunomodulators)IBA
01/2009 - 07/2004
1CytokinesIBA
08/2023
1Small Interfering RNA (siRNA)IBA
01/2023
1tisagenlecleucelIBA
12/2022
1fludarabineIBA
01/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021
1CD19 AntigensIBA
01/2020
1ParaffinIBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1Zoledronic Acid (Zometa)FDA Link
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1InterferonsIBA
02/2019
1AntigensIBA
01/2017
1Neoplasm Antigens (Tumor Antigens)IBA
01/2017
1EpitopesIBA
01/2017
1EnzymesIBA
10/2015
1Proteins (Proteins, Gene)FDA Link
10/2015
1Adenosine DeaminaseIBA
10/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2015
1IpilimumabIBA
10/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014
1Transforming Growth Factor-beta Type II ReceptorIBA
06/2014
1Niacinamide (Nicotinamide)FDA LinkGeneric
01/2013
1Hormones (Hormone)IBA
11/2011
1Interferon-gamma (Interferon, gamma)IBA
05/2009
1DNA (Deoxyribonucleic Acid)IBA
03/2008
1Angiogenesis InhibitorsIBA
04/2006
1hydrocortisone acetate (Cortifoam)FDA LinkGeneric
03/2004

Therapy/Procedure

21Therapeutics
01/2024 - 03/2004
12Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023 - 03/2006
11Immunotherapy
01/2023 - 07/2004
4Drug Therapy (Chemotherapy)
11/2011 - 03/2006
3Salvage Therapy
12/2022 - 01/2020
1Injections
01/2020
1Tissue and Organ Harvesting
09/2019
1Prostatectomy (Retropubic Prostatectomy)
01/2019
1Aftercare (After-Treatment)
01/2013